AIM
MGNX icon

Aigen Investment Management’s MacroGenics MGNX Stock Holding History

Aigen Investment Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,197
Closed -$341K – 927
2024
Q1 		$341K Buy
+23,197
New +$351K 0.07% 392
2020
Q4 		– Sell
-18,572
Closed -$468K – 936
2020
Q3 		$468K Sell
18,572
-5,818
-24% -$159K 0.06% 416
2020
Q2 		$681K Buy
+24,390
New +$424K 0.09% 365

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aigen Investment Management's MGNX Position: Q2 2024 in Review

Aigen Investment Management sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 23,197 shares — an estimated $341K sold.

Aigen Investment Management first reported a position in MGNX in Q2 2020 and held it in 3 quarters. The position peaked at $681K in Q2 2020. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • Aigen Investment Management reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • Aigen Investment Management sold 23,197 MacroGenics shares in Q2 2024, an estimated $341K.
  • Aigen Investment Management first reported a position in MacroGenics in Q2 2020 and held it in 3 quarters.
  • Aigen Investment Management's MacroGenics position peaked at $681K in Q2 2020.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on Aigen Investment Management's 13F filing for Q2 2024, filed 9 Aug 2024.